 |
Senior Member
|
|
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
|
|
|
Senior Member
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
|
I think it is ProSavin
Professor Stéphane Palfi commented : "The preclinical proof-of-concept studies together with clinical data from the first two dose levels in the Phase I/II study suggest that ProSavin may provide sustained and meaningful benefit to patients and could reduce or eliminate the debilitating complications associated with oral dopamine replacement therapy. In the initial indication of moderate to late-stage Parkinson's disease, ProSavin potentially offers significant advantages to the current alternatives of Deep Brain Stimulation or mechanical delivery of continuous dopamine."
Read more: http://www.fiercebiotech.com/press-r...#ixzz0etMcD06V
__________________
Jean B
This isn't the life I wished for, but it is the life I have. So I'm doing my best.
|